Clinical trial

Semaglutide 2.4mg for Low Responders After Bariatric Surgery

NCT06287307

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-05-01

PhasePHASE4

Study timeline

Study start (estimated)2024-05-01Date precision: month

Registry last updated2024-03-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Obesity, Morbidunresolved

Weight Gainunresolved

Interventions

PlaceboOTHER

Semaglutide 2.4 MG/0.75 ML Subcutaneous Solution [WEGOVY]DRUG

Sponsors & collaborators

Zuyderland Medisch Centrumlead sponsor

Nederlandse Obesitas Kliniekcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06287307 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.